Rec. for Authors

Sample Article

Photo Consent

Submission Checklist











































The Israeli Journal of Emergency Medicine (ISRJEM) is a peer-reviewed Israeli journal that publishes articles of interest to emergency physicians. ISRJEM is published by the Israeli Association for Emergency Medicine as part of its mission to its members and the EM community at large. It is the Association's official journal.


ISRJEM focuses on content relevant to all aspects of emergency medicine (EM): clinical, educational, research and administration.  It also covers the entire spectrum of emergency medicine practice and all patient age groups including clinical care, research and education. We welcome article submissions in the following categories: Advances (original research), State of the Art (review articles), Pharmacotherapy, Controversies (commentaries and special articles), Education, Methodology: the Science of EM, Case Reports, EM Administration, Letters, Resident Issues, Diagnostic Challenge, Pediatric EM, Toxicology, Small Urban and Rural Issues, EMS, resident forum, Humour and Humanity, International EM, and Media Reviews. ISRJEM publishes articles in English.

Suggested article length is 2000-3000 words for feature articles, 1000-2000 for Case Reports, 600-1800 for Humour and Humanity or Commentary articles, 500-1000 for Diagnostic Challenge, and 200-400 for Letters. Our goal is that ISRJEM provides high quality content in a succinct, easy-to-read format; therefore accepted articles may be edited for clarity and brevity.


Please email ISRJEM with your email address, mailing address, and profession (Physician, nurse, paramedic, etc) at: ISRJEM Submissions

Authors should conform to the general guidelines laid out in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (1). Articles prepared in accordance with these guidelines will not be rejected for reasons of style or format.

Formatting: Manuscripts should be double-spaced throughout, from title page to references. Authors should use a consistent 12-point font, preferably Times New Roman. Right margins should be unjustified (ragged). Special formats, including Endnotes, superscripts, subscripts, small caps, paragraph adjustment and auto-numbering should be avoided, as all make the editorial process more difficult. Number the pages consecutively, beginning with the title page, and provide a running header.

Title page: The title page should include the article title, the authors' name(s) as they should appear in print, and the affiliations of all authors. The name, address, telephone number, fax number, and email address for the corresponding author should be provided, running header or footer, key MeSH words, in addition to a word count. The next page should include the group authorship, disclaimers, sources of support and acknowledgment.

Abstracts: Structured abstracts (Objectives, Methods, Results, Conclusions) of up to 250 words are required for original research articles, systematic review articles and meta-analyses. Unstructured abstracts should be provided for case reports, commentaries and most other articles. The latter should summarize the problem or objective, main points, and conclusions of the article in 150-200 words. Abstracts are not required for editorials, news items or Humour and Humanity pieces.

Ethical considerations: For investigations involving human subjects, the "Methods" section should specify the nature of the patient consent that was obtained at the time of enrolment. Authors must clarify that an appropriate ethics committee or investigational review board approved the research.
References: Within the text, references should be numbered in the order they appear, using standard text and angular brackets rather than superscript. Avoid special formats, including auto-numbering for sections or references. References should report all authors up to 6. When there are more than 6 authors, the first 6 should be cited, followed by "et al."



Electronic submission by email or CD ROM is required. Manuscripts submitted as email attachments should be forwarded to, in Microsoft Word format. All submissions should be accompanied by a brief cover letter. Within the cover letter, the corresponding author should identify potential conflicts of interest, specify each author's contribution to the work, and indicate that all co-authors have provided their permission to publish the manuscript.

Photographs and digital image files are acceptable. If figures are submitted electronically they must meet the specifications outlined in the Canadian Medical Association Publications' Digital Art Submission form. If figures, illustrations or tables have been taken or adapted from a previous publication, the authors are responsible to acquire written permission from the publishers to reproduce these items. If patients could possibly be identified by photographs or descriptions within the manuscript, authors are responsible to acquire written consent from the patients to publish their photographs or descriptions.

Previous publication

In accordance with "Uniform Requirements"(1), manuscripts will be considered with the understanding by ISRJEM that they have not been previously published nor are under consideration by another journal. Authors are referred to "Uniform requirements" for detailed guidelines on previous publication and exceptions.

Review and editorial processes

All submissions are reviewed by the editor-in-chief or a senior associate editor within 2 weeks. Articles that are clearly unsuitable for ISRJEM will be returned to the authors at this time. Those considered relevant to EM will be forwarded for blinded peer review. Peer review comments will be forwarded electronically to a decision editor, who will decide whether the article should be accepted, rejected or revised. This editor will compose an editor's response letter to the author. In most cases, authors can expect an editor's response within 6-8 weeks of original manuscript submission.

Revised manuscripts will be forwarded to the decision editor, who will determine whether review comments have been addressed. The decision editor, often in concert with the editor-in-chief or senior associate editor will make a final decision regarding publication. Accepted articles will be edited for clarity, brevity and style, and authors will have the opportunity to review and approve revisions prior to publication. Manuscripts submitted to ISRJEM will be treated with respect and confidentiality. After acceptance, transfer of copyright must be made in writing to the ISRJEM.

Financial disclosure (conflict of interest)

Prior to publication, all authors will be required to sign a financial disclosure form, indicating any financial interests or potential conflicts of interest they have relating to the manuscript.

Additional instructions: To submit to specific ISRJEM sections:

EM Advances: EM advances accepts articles that present primary
data arising from original research. Authors of randomized clinical trials should conform to the criteria specified in the CONSORT statement (2) checklist. The revised CONSORT statement can be viewed at Authors of retrospective reviews should, where appropriate, incorporate the design elements discussed by Gilbert and colleagues (3). "EM Advances" articles should be from 2000-3000 words, excluding tables, figures and references. The Introduction should discuss study justification, and a priori objectives and hypotheses. The Methods section should include a description of the overall study design, the study setting, time period, patients studied (with eligibility criteria), a description of the intervention, the primary and secondary outcome measures, and the statistical analysis employed. The Results section should include primary and secondary results, with appropriate tables and figures. The Discussion section should highlight the important study findings and discuss these in the context of previous published literature. In addition, the Discussion should identify limitations of the research and future directions. Conclusions should be stated in 1 paragraph and should be supported by the data. A structured Abstract should be prepared (see above).

State of the Art (review articles): "State of the Art" is devoted to topical reviews of the recent and past scientific literature. Review articles should attempt to define the "state of the art" for the topic or research question addressed. Systematic reviews are preferred, but narrative reviews will be considered for publication. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated, and the selection process should be described in the paper. Expected length for a "State of the Art" review is 3000-4000 words (not including tables, figures and references). Authors of systematic reviews incorporating meta-analysis should refer to the QUOROM statement on improving the quality of reports of meta-analysis of randomized controlled trials.4 Authors of systematic reviews without meta-analysis should refer to the systematic review series edited by Cook and colleagues (5) and Mulrow et all (6).
Authors of systematic review articles should: define a clear and clinically relevant research question; retrieve and describe relevant reviews published to date; document their limitations and justify the need for a more comprehensive review (7); define the search strategy used to identify primary articles (8); describe the methods used to select primary studies; specify inclusion and exclusion criteria (criteria for selecting primary studies should be based on population studied, intervention or exposure, study outcomes, and study methodology); perform a blinded assessment of the quality of the selected articles; assess the reliability of this process by measuring the agreement of 2 evaluators (9,10); account for all studies identified by the search and justify exclusions; describe the method of combining study results; discuss variation within and between studies; state their conclusions; compare their conclusions to the literature and current standard of care; outline the limitations of the review; suggest areas for future research.
The Abstract for a systematic review should include the following headings: Objectives, Data source, Study selection, Data extraction, Data synthesis, and Conclusion.

Pharmacotherapy: The goal of the "Pharmacotherapy" section is to provide evidence-based reviews of current trends in pharmacology and therapeutics, and of drug therapies commonly used in the emergency department. Reviews may focus on new pharmaceutical modalities relevant to the emergency department or on new indications for older medications.
Reviews should include a brief Introduction discussing the background of the agent(s) under review and defining the paper's objective. This should be followed by a Pharmacology and pharmacokinetics section that includes comparisons to other drugs within the same class should also be included if possible. This section should not be over detailed but sufficient enough to allow the prescriber to understand the basic pharmacology (mechanism) of the new agent and appreciate some of the pharmacokinetic principles that dictate dosing of the agent (e.g., onset, duration, clearance [renal vs. hepatic], half-life). A section on Clinical evidence should encompass most of the paper and should critically evaluate the current evidence that surrounds the use of this agent. The author should be encouraged to provide a thorough review of the literature to ensure all pertinent literature on the topic is captured. The author should then be able to consolidate the current evidence on both efficacy and safety and cost on the use of this agent as well as limitations and unanswered questions that arise from the current literature on the topic of focus. Finally, the author should outline the current role of the agent of focus as it pertains to use in the emergency department. The current place in therapy compared to the standard of care should be outlined with final recommendations on indications, dose, route and duration of care along with appropriate monitoring parameters.

"Selected Articles" is devoted to evidence-based article reviews. The aims of this section are to demonstrate the use of the critical review format, to review articles of interest to emergency physicians, and to determine the relative validity and usefulness of these articles. Review articles address 3 key questions: What are the results? Are the results valid? and will the results help me care for my patients? In each issue of ISRJEM, we hope to
have important articles reviewed by emergency physicians with a special interest or expertise in the topic under discussion. The preferred review methodology, including critical review forms, is described in "Users Guide to the Medical Literature," a series published in the Journal of the American Medical Association. Authors wishing to view samples of appropriate article review format may visit the NHS Research and Development
Centre for Evidence-Based Medicine Web site ( or peruse articles published in ACP Journal Club. CATs and selected article reviews are selected for publication based on the quality of the review and the topic's level of interest to emergency physicians.

Case Reports: Case reports are most valuable if they illustrate an important error or practice point for emergency physicians, if they identify a previously not described finding or phenomenon, or if they describe a therapy that could lead to future research or a change in practice. Suggested article length for case reports is 1000-2000 words. Our goal is that ISRJEM provides high quality content in an easy-to-read format; therefore brevity and active voice are encouraged. Authors should conform to the general guidelines laid out in "Uniform Requirements" (1). Manuscripts submitted to "Case Reports" should include: 1. a brief Introduction (1-2 paragraphs describing why the topic is important); 2. the Case Report, consisting of a succinct summary of relevant historical, physical, laboratory and imaging findings, emergency department diagnosis, management, and disposition, and relevant follow-up information (e.g., patient outcome, findings at laparotomy); 3. a Discussion, summarizing what the case illustrates and what the teaching points are; 4. a 1-paragraph Conclusion.

Brief Reports: Brief reports of original studies should be 650-1200 words excluding tables, figures and references. Brief reports will be limited to 1 table or figure and 10 references.

Letters: Letters should be addressed to the editor, ISRJEM. Letters will be considered for publication if they relate to topics of interest to emergency physicians in urban, rural, community or academic settings. Letters are generally not peer reviewed but may be edited for brevity and clarity. Letters will generally be limited to 400 words and 5 references. Letters responding to a previously published ISRJEM article should reach ISRJEM head office within 6 weeks of the article's publication. Authors whose work is discussed will be given an opportunity to respond.

Break in the Action: Submissions should reflect the challenges of working in medicine. Generally they should add to our understanding of the physician experience, particularly in Israel. Articles are peer reviewed and are to be less than 1000 words in length.

Images in Medicine: Photographic submissions should be of relevance to the practice of emergency medicine. These may include diagnostic challenges (with accompanying text) or images that are reflective of the cultural and operational aspects of emergency medicine. Images should be of sufficient resolutions to reproduce at 1200 x 1024 (minimum 2 mega pixel), and be transmitted electronically. Photography displaying the face or recognizable features of human subjects requires a signed copy of the Photography Consent Form.  


Only under in exceptional cases will ISRJEM publish material that has appeared elsewhere. Under these circumstances, the authors must abide by the following:

The International Committee of Medical Journal Editors states the following:

III.D.3. Acceptable Secondary Publication

Certain types of articles, such as guidelines produced by governmental agencies and professional organizations, may need to reach the widest possible audience. In such instances, editors sometimes choose deliberately to publish material that is also being published in other journals, with the agreement of the authors and the editors of those other journals. Secondary publication for various other reasons, in the same or another language, especially in other countries, is justifiable, and can be beneficial, provided all of the following conditions are met.

1. The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version.

2. The priority of the primary publication is respected by a publication interval of at least one week (unless specifically negotiated otherwise by both editors).

3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient.

4. The secondary version faithfully reflects the data and interpretations of the primary version.

5. The footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part and states the primary reference. A suitable footnote might read: "This article is based on a study first reported in the [title of journal, with full reference]."

Permission for such secondary publication should be free of charge.

6. The title of the secondary publication should indicate that it is a secondary publication (complete republication, abridged republication, complete translation, or abridged translation) of a primary publication. Of note, the National Library of Medicine does not consider translations to be "republications," and does not cite or index translations when the original article was published in a journal that is indexed in MEDLINE.



Prospective authors with questions regarding a submission, or those who wish to discuss a paper in the development stage are encouraged to contact the editor-in-chief or the appropriate section editor listed in the Appendix below. Email correspondence is preferred.

1. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Available:
2. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276(8):637-9
3. Gilbert EH, Lowenstein SR, Koziol-McLain J, Barta DC, Steiner J. Chart reviews in emergency medicine research: Where are the methods? Ann Emerg Med 1996;27:305-8
4. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896-900
5. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997;126:376-80
6. Mulrow C, Langhorne P, Grimshaw J. Integrating heterogeneous pieces of evidence in systematic reviews. Ann Intern Med 1997;127:989-95
7. Hunt DL, McKibbon KA. Locating and appraising systematic reviews. Ann Intern Med 1997;126:532-8
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12
10. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992;45:255-65






























Israeli Journal of Emergency Medicine